What is Wave Life Sciences Ltd (WVE) stock price today?

Wave Life Sciences Ltd (WVE) currently trades at $7.06 per share. The stock has a market capitalization of $1.36B and a P/E ratio of —x.

Is WVE stock a buy, sell, or hold in 2026?

Based on WallStSmart's proprietary analysis, Wave Life Sciences Ltd has a Smart Value Score of 33/100 (Grade F), resulting in a "Strong Sell" investment rating. The Piotroski F-Score is —/9 and Altman Z-Score is —.

What is Wave Life Sciences Ltd's revenue and earnings?

Wave Life Sciences Ltd has trailing twelve-month (TTM) revenue of $71.80M with profit margins of -255.70%. Earnings per share (EPS) is $-1.05.

WVE

Wave Life Sciences Ltd

NASDAQ: WVE · HEALTHCARE · BIOTECHNOLOGY

$7.06

+0.14% today

Updated 2026-04-30

Market cap

$1.36B

P/E ratio

—

P/S ratio

18.89x

EPS (TTM)

$-1.05

Dividend yield

—

52W range

$5 – $22

Volume

4.6M

Market cap

$1.36B

P/E ratio

—

P/S ratio

18.89x

EPS (TTM)

$-1.05

Dividend yield

—

52W range

$5 – $22

Volume

4.6M

WallStSmart proprietary scores

out of 100

Grade: F

Strong Sell

Investment rating

8.0

Growth

5.0

Quality

C+

2.0

Profitability

5.0

Valuation

C+

—/9

Piotroski F-Score

—

Altman Z-Score

—

Industry rank

—

View all highly rated stocks (75+) →206 stocks currently score above 75

Price targets

Analyst target

$23.12

+227.48%

12-Month target

—

Intrinsic (DCF)

—

Margin of safety

—

2 Strong Buy14 Buy0 Hold0 Sell0 Strong Sell

Price chart

X-Ray snapshot

Strengths

+ Revenue growth 316.90% QoQ

Risks

- Thin margins at -255.70%

- Negative free cash flow $-32.13M

Key financials

Revenue Net Income Free Cash Flow

Metric	2022	2023	2024	2025	TTM
Revenue	$3.65M	$113.31M	$108.30M	$42.73M	$71.80M
Net income	$-161.82M	$-57.51M	$-97.01M	$-204.38M	$-53.18M
EPS	—	—	—	—	$-1.05
Free cash flow	$-129.14M	$-20.55M	$-151.96M	$-188.21M	$-32.13M
Profit margin	-4,434.72%	-50.76%	-89.57%	-478.33%	-255.70%

Peer comparison

Company	Mkt Cap	Score	Growth	Profit	Value	Quality	MoS	Rating
WVE	$1.36B	33	8.0	2.0	5.0	5.0	—	Avoid
LLY	$760.43B	78	10.0	10.0	5.0	6.5	—	Strong Buy
JNJ	$547.28B	59	4.7	9.0	3.3	6.0	-43.54%	Buy
ABBV	$360.63B	63	4.0	8.0	4.7	5.0	-29.31%	Buy
UNH	$336.47B	54	5.3	5.5	7.3	4.8	+42.09%	Buy
AZN	$287.11B	64	6.7	8.0	5.3	5.0	+4.07%	Buy

Smart narrative

Wave Life Sciences Ltd trades at $7.06. Our Smart Value Score of 33/100 indicates the stock is weak. TTM revenue stands at $71.80M. with profit margins at -255.70%.

Frequently asked questions

What is Wave Life Sciences Ltd's stock price?

Wave Life Sciences Ltd (WVE) trades at $7.06.

Is Wave Life Sciences Ltd overvalued?

Smart Value Score 33/100 (Grade F, Strong Sell).

What is the price target of Wave Life Sciences Ltd (WVE)?

The analyst target price is $23.12, representing +227.5% upside from the current price of $7.06.

What is Wave Life Sciences Ltd's revenue?

TTM revenue is $71.80M.

Company info

SectorHEALTHCARE

IndustryBIOTECHNOLOGY

CountryUSA

ExchangeNASDAQ

CurrencyUSD

Quick metrics

P/S ratio18.89x

ROE-53.10%

Beta-1.32

50D MA$10.27

200D MA$10.21

Shares out0.19B

Float0.13B

Short ratio—

Avg volume4.6M

Performance

1 week—

1 month—

3 months—

YTD—

1 year—

3 years—

5 years—

Compare

WVE vs LLY →WVE vs JNJ →WVE vs ABBV →Stock screener →